This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Center for Diagnostics and Telemedicine of the Moscow Healthcare Department in Russia is highlighting ultrasound training phantoms it has created, including a fetal phantom, that aims to help sonographers-in-training. The fetal phantom replicates the anatomical features of a 20-week-old fetus and produces an ultrasound image that mimics those obtained by specialists during scans.
Radon Medical Imaging has purchased Alpha Imaging, a large imaging equipment distributor and services provider based in Willoughby, OH. Terms of the transaction were not disclosed. The acquisition expands Radon’s presence to 24 states, up from five over the last two years, and the company now boasts more than 200 team members, including more than 120 highly trained field service technicians, Radon said.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Telix Pharmaceuticals is expanding its theranostic pipeline with newly acquired assets targeting fibroblast activation protein (FAP) in nuclear medicine. The company has entered into asset purchase and exclusive worldwide in-license agreements for a suite of clinically validated FAP-targeting therapeutic and precision medicine radiopharmaceutical candidates.
A new analysis in JACR estimates that spotting the signs of a previously undetected stroke could benefit up to 200,000 people in the United States every year.
264
264
Sign up to get articles personalized to your interests!
Diagnostic Imaging Brief brings together the best content for architecture professionals from the widest variety of industry thought leaders.
A new analysis in JACR estimates that spotting the signs of a previously undetected stroke could benefit up to 200,000 people in the United States every year.
Lung MRI developer Polarean Imaging has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MRI chest coil to be used with GE HealthCare's (GEHC) 3-tesla (3T) MRI scanners to visualize xenon-129 nuclei. Polarean now supports xenon MRI scanning of both clinical and research patients on GEHC, Philips, and Siemens Healthineers scanners.
tim.hodson Wed, 11/20/2024 - 16:08 Nov. 19, 2024 — Results of a UCLA study recently published in the Journal of Breast Imaging demonstrates that Transpara's proven Breast AI may improve cancer detection by decreasing false negative cancers when applied to a heterogeneous, real-world U.S. screening population. The study, " External Validation of a Commercial Artificial Intelligence Algorithm on a Diverse Population for Detection of False Negative Breast Cancers ," showed that Transpara accura
Advanced visualization software firm Imaging Biometrics has renewed its distribution agreement with GE HealthCare (GEHC). Under the agreement, GEHC will now sell Imaging Biometrics’ IB Neuro and IB Delta T1 platforms directly to both existing and new customers. IB Neuro and IB Delta T1 maps are frequently used together to assist in diagnosing, planning, and monitoring treatment response for brain tumor patients, Imaging Biometrics said.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
Women consist of about one out of every four radiologists in the U.S., but a student-led initiative is working to bring that number up and close the gender gap. Women in Radiology Education (WIRED), formed in 2020 at the University of Alabama-Birmingham (UAB), is a student-led group dedicated to advancing radiology mentorship, research, and service opportunities for women in medical school.
In 2023 alone, the healthcare industry experienced tens of millions of compromised records due to cyberattacks and data breaches, highlighting the critical need for stringent data protection measures. As healthcare organizations increasingly adopt AI, safeguarding medical data isn’t just a technical requirement – it’s a governance imperative. Health systems must prioritize understanding how their AI partners will protect sensitive information while maintaining compliance with stringent regulator
France-based Supersonic Imagine has launched HEPAVu, an ultrasound imaging system designed for liver specialists. HEPAVu provides real-time imaging and specialized features designed to improve both clinical accuracy and user experience. Features include 2D real-time shearwave elastography, Q-Live PL.U.S biomarkers, viscosity biomarkers, an intuitive interface, and tools for microvascularization, perfusion dynamics, and vascular flow.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
This Nurse Practitioner Week, we’re proud to spotlight the vital role of Radiology's nurse practitioners who are essential to the care of patients having diagnostic and interventional procedures.
Everlight is partnering with DataFirst to streamline radiology operations as the specialty faces rising imaging volumes. The partnership will see DataFirst's Silverback platform integrated into Everlight's services. Silverback creates and tracks unique identifiers, loads balance studies, deploys high availability, accepts and routes studies, exports DICOM objects, and prevents data loss.
Buying new, used or refurbished medical imaging equipment for your healthcare facility is always exciting, but there are lots of details to take care of before it’s ready for patients.
Positron Corporation is partnering with Upbeat Cardiology Solutions to supply the former's PET/CT systems and services. The cooperation aims to improve cardiology practices by supplying advanced imaging technology and software to streamline the adoption of cardiac PET/CT imaging. Upbeat Cardiology Solutions offers an end-to-end approach for private practices transitioning to cardiac PET-CT imaging.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
In a recent interview, Richard Duszak, MD, discussed new study findings that showed over nine percent annual increases in ultrasound, CT and MRI interpretation by office-based non-physician practitioners (NPPs) between 2013 and 2022.
Cardiac MR software developer Myocardial Solutions has received clearance from the U.S. Food and Drug Administration (FDA) for the latest version of its MyoStrain software. MyoStrain is a 10-minute, MRI-based heart function test that provides physicians with diagnostic markers to support the early assessment of heart dysfunction. MyoStrain 6.0 introduces a suite of new features, with initial feedback from technicians and physicians pointing to improved user experience, ease of access to centrali
The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
A new study suggests that integrating an AI program to analyze echocardiograms could reduce the time it takes to receive results, ultimately enabling more timely medical interventions.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
Medical technology is constantly evolving, offering new and innovative tools for diagnosis and treatment. Class IV laser therapy is a non-invasive therapeutic approach gaining traction in the field of pain management and tissue healing.
CT-defined coronary artery calcification (CAC) scores can help predict the occurrence of conditions such as heart attack or stroke in lung cancer patients, researchers have reported. "[We found] a meaningful impact of the CAC score on overall survival and [that it] was associated with the occurrence of major cardiovascular events," wrote a team led by Hans-Jonas Meyer of the University of Leipzig in Germany.
Employee churn is a fact of life for any employer, but a high level of churn is one of the worst things to happen to any organization. That’s because replacing employees takes up so much time, resources, and money. Turnover costs for entry-level employees alone cost a massive 50% of their salaries. That’s an expense you might not be able to afford.
Absent any last-minute Congressional action, physicians will suffer a 2.83% fee schedule reduction for 2025. This is slightly more of a cut than had been predicted in the Medicare Physician Fee Schedule (MPFS) Proposed Rule that was issued in July. As we reported in our analysis of the Proposed Rule , this reduction in payments continues a trend that has seen the Medicare fee schedule reduced by nearly 10% over the past 10 years.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content